Pharmafile Logo
Pharmafocus logo
Advanced Search

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain

December 16, 2024
LEO Pharma, eczema

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …

News
Press release

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

December 13, 2024
CPHI Milan, CPhI, networking

13 December 2024 – Amsterdam, the Netherlands –  CPHI Milan – the world’s largest pharma event – hosted last month …

News
Press release

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

December 12, 2024
Corporate, Deep Science Ventures, General Inception, fibrosis, venture

12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and …

News
Press release

NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE

December 10, 2024
Mounjaro, NICE, lilly, weight-loss

BASINGSTOKE, 5th December 2024 – Eli Lilly and Company announced today that the National Institute for Health and Care Excellence …

News
Press release

UCB presents epilepsy research at American Epilepsy Society Annual Meeting

December 9, 2024
Research and Development American Epilepsy Society, Dravet Syndrome, Neurology, UCB, sleep

Belgian-based biopharmaceutical company UCB has announced it will present 32 abstracts at the American Epilepsy Society (AES) Annual Meeting – …

News

Gemma Cathcart appointed managing partner at Langland

November 25, 2024
Corporate, Langland

Langland, a medical life sciences company with focuses on areas surrounding Clinical Trial experience, Medical Strategy and Education, Public Relations …

Appointment

Ceryx Medical Initiates First-In-Human Study of the Cysoniâ„¢ RSA Pacemaker

November 21, 2024
Ceryx Medical, Devices, biotech

Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using …

News
Press release

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

November 20, 2024
AMR Week, Glox Therapeutics, antimicrobial resistance

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding …

News
Press release

Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List

November 19, 2024
Chiesi, Corporate, best workplace

Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best …

News
Press release

Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion

November 18, 2024
barinthius Bio

Eight participants achieved HBsAg loss at any time. Two participants met criteria for functional cure. Two participants who discontinued NUC …

News
Press release

Antibacterial peptides instrumental in efficiency against resistant bacteria

November 18, 2024
Research and Development AMR, Chalmers Institute of Technology, Infections and infestations, MRSA, antibacterial peptides

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, …

News

Spinal cord stimulator with AI technology receives CE Mark certification

November 13, 2024
Research and Development AI, EU, Nevro, Pain, spinal cord stimulation

The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …

News

J&J seek approval for first drug to treat high-risk smoldering myeloma

November 13, 2024
Research and Development FDA, J&J, Rare Diseases, bone marrow

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the …

News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024
Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …

News

CMS commences formal review for Topical Oxygen Therapy coverage

November 11, 2024
Wound Healing, topical oxygen therapy, wound care

11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …

News
Press release

Johnson & Johnson receive MHRA approval for BALVERSA

November 8, 2024
Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer

BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …

News

SolasCure partners with US Army for better wound care technology

November 6, 2024
Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …

News

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

November 5, 2024
Research and Development NorthWest Ehealth, clinical trials

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …

News
Press release

FlyPharma Vienna 2024: An Event to Remember!

November 4, 2024
Corporate, FlyPharma 2024, Samedan, event

Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …

News
Press release

Valneva Scotland supports local cancer charity Team Jak Foundation 

October 31, 2024
Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines

Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …

News
Press release
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026